ANVS

Annovis BioF

NYSE / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

AI scenario view

RankAlpha Sentiment AI

B+

Bull case

20%

Probability

Target price

$1.80

Analysis reference price unavailable

Analysis 2025-11-30 · RankAlpha Sentiment AI

Most likely

Base case

50%

Probability

Target price

$0.90

Analysis reference price unavailable

Analysis 2025-11-30 · RankAlpha Sentiment AI

B-

Bear case

30%

Probability

Target price

$0.45

Analysis reference price unavailable

Analysis 2025-11-30 · RankAlpha Sentiment AI

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2025-11-30

AI commentary

Market tone is cautious to negative given low price and high dilution probability; commentary centers on financing risk and binary clinical outcomes [#10Qp12], [#PR-2025-07-15]. Recent trading volume and press suggest limited investor conviction, with occasional speculative spikes tied to trial rumors [#news-week].

RankAlpha Sentiment AI - 2025-11-30

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-01-31catalystFinancing / dilutionHigh impact

Need for additional capital could lead to dilution and downward pressure if raised at low prices; likelihood elevated for early‑stage biotechs [#10Qp12].

2026-03-31eventRegulatory interactions / FDA feedbackHigh impact

Positive or negative regulatory feedback on development pathways could materially re-rate valuation given small market cap and binary outcomes [#10Qp12].

2026-06-30eventClinical data readouts / trial updatesHigh impact

Potential Phase 2/extension study updates or safety/tolerability disclosures for lead programs may move the stock [#10Qp12], [#PR-2025-07-15].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2025-11-30 • Updated nightlySource: Internal modelMethodology